Kaken Pharmaceutical Statistics

Total Valuation

TYO:4521 has a market cap or net worth of JPY 180.89 billion. The enterprise value is 104.98 billion.

Market Cap	180.89B
Enterprise Value	104.98B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Mar 28, 2025

Share Statistics

TYO:4521 has 37.87 million shares outstanding. The number of shares has increased by 0.62% in one year.

Current Share Class	n/a
Shares Outstanding	37.87M
Shares Change (YoY)	+0.62%
Shares Change (QoQ)	+0.00%
Owned by Insiders (%)	5.02%
Owned by Institutions (%)	34.23%
Float	32.68M

Valuation Ratios

The trailing PE ratio is 8.81 and the forward PE ratio is 23.46.

PE Ratio	8.81
Forward PE	23.46
PS Ratio	1.94
PB Ratio	1.17
P/TBV Ratio	1.22
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	5.11
EV / Sales	1.12
EV / EBITDA	n/a
EV / EBIT	4.03
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.38, with a Debt / Equity ratio of 0.02.

Current Ratio	4.38
Quick Ratio	3.75
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	1,133.26

Financial Efficiency

Return on equity (ROE) is 13.90% and return on invested capital (ROIC) is 10.75%.

Return on Equity (ROE)	13.90%
Return on Assets (ROA)	9.01%
Return on Invested Capital (ROIC)	10.75%
Return on Capital Employed (ROCE)	15.87%
Revenue Per Employee	82.25M
Profits Per Employee	18.08M
Employee Count	1,135
Asset Turnover	0.52
Inventory Turnover	1.95

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.05% in the last 52 weeks. The beta is 0.16, so TYO:4521's price volatility has been lower than the market average.

Beta (5Y)	0.16
52-Week Price Change	+35.05%
50-Day Moving Average	4,411.90
200-Day Moving Average	4,095.62
Relative Strength Index (RSI)	68.61
Average Volume (20 Days)	275,530

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TYO:4521 had revenue of JPY 93.35 billion and earned 20.53 billion in profits. Earnings per share was 541.97.

Revenue	93.35B
Gross Profit	57.87B
Operating Income	26.07B
Pretax Income	26.60B
Net Income	20.53B
EBITDA	n/a
EBIT	26.07B
Earnings Per Share (EPS)	541.97

Full Income Statement

Balance Sheet

The company has 79.75 billion in cash and 3.85 billion in debt, giving a net cash position of 75.90 billion or 2,004.10 per share.

Cash & Cash Equivalents	79.75B
Total Debt	3.85B
Net Cash	75.90B
Net Cash Per Share	2,004.10
Equity (Book Value)	155.26B
Book Value Per Share	4,099.33
Working Capital	98.86B

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 62.00%, with operating and profit margins of 27.92% and 21.99%.

Gross Margin	62.00%
Operating Margin	27.92%
Pretax Margin	28.49%
Profit Margin	21.99%
EBITDA Margin	n/a
EBIT Margin	27.92%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 150.00, which amounts to a dividend yield of 3.13%.

Dividend Per Share	150.00
Dividend Yield	3.13%
Dividend Growth (YoY)	26.67%
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	-0.62%
Shareholder Yield	2.52%
Earnings Yield	11.35%
FCF Yield	n/a

Dividend Details

Stock Splits

The last stock split was on September 28, 2015. It was a reverse split with a ratio of 0.5.

Last Split Date	Sep 28, 2015
Split Type	Reverse
Split Ratio	0.5

Scores

TYO:4521 has an Altman Z-Score of 4.82.

Altman Z-Score	4.82
Piotroski F-Score	n/a